Kane Biotech Inc.
KNBIF
$0.0451
$0.00821.56%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 4.64M | 4.46M | 4.07M | 3.48M | -3.88M |
| Total Depreciation and Amortization | 152.40K | 159.20K | 156.70K | 167.30K | 172.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -7.01M | -7.00M | -6.90M | -6.50M | 1.74M |
| Change in Net Operating Assets | -832.70K | -630.50K | -617.10K | -582.70K | 405.40K |
| Cash from Operations | -3.05M | -3.01M | -3.29M | -3.43M | -1.56M |
| Capital Expenditure | -24.00K | -18.20K | -19.70K | -18.10K | -10.60K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | 7.04M | 7.04M | 6.99M | 6.99M | -- |
| Other Investing Activities | -426.10K | 489.70K | 1.12M | 1.10M | 1.43M |
| Cash from Investing | 6.59M | 7.52M | 8.09M | 8.07M | 1.42M |
| Total Debt Issued | -- | -- | 0.00 | 1.00M | 1.00M |
| Total Debt Repaid | -6.62M | -6.65M | -6.65M | -6.65M | -649.90K |
| Issuance of Common Stock | 2.07M | 619.10K | 248.70K | 415.30K | 415.30K |
| Repurchase of Common Stock | -- | -- | -16.20K | -16.20K | -16.20K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1.46M | -1.65M | -1.23M | -1.25M | 148.10K |
| Cash from Financing | -4.43M | -5.62M | -5.59M | -4.74M | 668.20K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Change in Cash | -887.10K | -1.12M | -790.30K | -93.30K | 530.00K |